Alan Knuckman

Analyst Articles

The broader market’s powerful “V” recovery off its mid-October lows recouped all of last month’s losses and then some, with the S&P 500 hitting new all-time highs this week. But not all sectors have kept pace, and it is in these underperforming areas where traders should look for rebound candidates… Read More

Fears that the Federal Reserve’s quantitative easing program would decimate the U.S. dollar have proven unfounded. Despite all the so-called money printing, the greenback is at a four-and-a-half-year high versus a basket of currencies.  The run in the dollar may have exhausted itself though, as we saw key reversals in… Read More

Fears that the Federal Reserve’s quantitative easing program would decimate the U.S. dollar have proven unfounded. Despite all the so-called money printing, the greenback is at a four-and-a-half-year high versus a basket of currencies.  The run in the dollar may have exhausted itself though, as we saw key reversals in… Read More

“At the corner of happy and healthy,” it seems the leading U.S. drug store chains have gone their separate ways. While their products and services may be similar, their stock price action is another story. The operator of the nation’s second largest pharmacy chain, CVS Health Corporation (NYSE:… Read More

“At the corner of happy and healthy,” it seems the leading U.S. drug store chains have gone their separate ways. While their products and services may be similar, their stock price action is another story. The operator of the nation’s second largest pharmacy chain, CVS Health Corporation (NYSE:… Read More